AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-22514773_ITM" title="Facts and information about Determination of regulatory review period for purposes of patent extension: Cancidas.">Determination of regulatory review period for purposes of patent extension: Cancidas.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
Determination of regulatory review period for purposes of patent extension: Cancidas.
(From Chemical Business NewsBase - Federal Register)
The US Food and Drug Administration (FDA) has determined the regulatory review period for Cancidas (caspofungin acetate, US Patent No. 5,514,650, Merck & Co Inc) and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of …
Related articles from newspapers, magazines, journals, and more
-
- Determination of regulatory review period for purposes of patent extension;...
-
News wire article from: Chemical Business Newsbase
April 5, 2010
700+ words
-
- Determination of regulatory review period for purposes of patent extension:...
-
News wire article from: Chemical Business Newsbase
February 16, 2007
700+ words
-
- Determination of regulatory review period for purposes of patent extension;...
-
News wire article from: Chemical Business Newsbase
April 23, 2010
700+ words
-
- Determination of regulatory review period for purposes of patent extension;...
-
News wire article from: Chemical Business Newsbase
April 23, 2010
700+ words
-
- Determination of regulatory review period for purposes of patent extension;...
-
News wire article from: Chemical Business Newsbase
October 5, 2009
700+ words
